Biolife Sciences Inc logo

BLFE - Biolife Sciences Inc Share Price

$0.45 0.1  12.5%

Last Trade - 4:19pm

Sector
Healthcare
Size
Micro Cap
Market Cap £11.0m
Enterprise Value £11.0m
Revenue £n/a
Position in Universe th / 6647
Bullish
Bearish
Unlock BLFE Revenue
Momentum
Relative Strength (%)
1m -0.33%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -90.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Nov 2007 2008 2009 2010 2011 2012 2013E 2014E CAGR / Avg
0.006 6.41 8.60 0.000 0.000 0.000 -100.0%
-12.7
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 30 November 2012, BiolifeSciences Inc revenues was not reported. Net loss decreased31% to $202K. Basic Earnings per Share excludingExtraordinary Items increased from -$2.57 to -$0.94.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BLFE Revenue Unlock BLFE Revenue

Net Income

BLFE Net Income Unlock BLFE Revenue

Normalised EPS

BLFE Normalised EPS Unlock BLFE Revenue

PE Ratio Range

BLFE PE Ratio Range Unlock BLFE Revenue

Dividend Yield Range

BLFE Dividend Yield Range Unlock BLFE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BLFE EPS Forecasts Unlock BLFE Revenue
Profile Summary

Biolife Sciences Inc., formerly Rhino Novi Inc., is a commercialization accelerator, licensor and developer of technology for the healthcare, beauty and food, material science and beverage industry sector. The Company’s core business develops, licenses and distributes antimicrobial products, non-contract human temperature screening technology and touchless vending products. Its technology solutions include BioLife Eco-Safe Surface Sanitizer, which is a botanically-derived disinfectant that kills bacteria, fungi and viruses; Antimicrobial Copper Air Filters cleans the air and releases copper ions to protect against bacteria and germs found circulating in enclosed rooms and buildings and BioLife Intelligent Touchless Vending and Marketplaces that provides digital advertising and digital vending machines serving a wide range of personal protective equipment and antimicrobial products. Its non-contract human temperature screening technology solutions detects subjects’ body temperature.

Directors
Last Annual November 30th, 2012
Last Interim November 30th, 2012
Incorporated March 31, 2000
Public Since April 25, 2005
No. of Shareholders: n/a
No. of Employees: 565
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 38,038,486
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BLFE Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BLFE
Upcoming Events for BLFE
Frequently Asked Questions for Biolife Sciences Inc
What is the Biolife Sciences Inc share price?

As of 4:19pm, shares in Biolife Sciences Inc are trading at $0.45, giving the company a market capitalisation of £11.0m. This share price information is delayed by 15 minutes.

How has the Biolife Sciences Inc share price performed this year?

Shares in Biolife Sciences Inc are currently trading at $0.45 and the price has moved by 0.271k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biolife Sciences Inc price has moved by 0.192k% over the past year.

What are the analyst and broker recommendations for Biolife Sciences Inc?

There are no analysts currently covering Biolife Sciences Inc.

When will Biolife Sciences Inc next release its financial results?

Biolife Sciences Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2013-11-30
What is the Biolife Sciences Inc dividend yield?

Biolife Sciences Inc does not currently pay a dividend.

Does Biolife Sciences Inc pay a dividend?

Biolife Sciences Inc does not currently pay a dividend.

When does Biolife Sciences Inc next pay dividends?

Biolife Sciences Inc does not currently pay a dividend.

How do I buy Biolife Sciences Inc shares?

To buy shares in Biolife Sciences Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Biolife Sciences Inc?

Shares in Biolife Sciences Inc are currently trading at $0.45, giving the company a market capitalisation of £11.0m.

Where are Biolife Sciences Inc shares listed? Where are Biolife Sciences Inc shares listed?

Here are the trading details for Biolife Sciences Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: BLFE
What kind of share is Biolife Sciences Inc?

We were not able to load our ranking data for Biolife Sciences Inc

Is there a Biolife Sciences Inc share price forecast 2021?

We were not able to load any forecast data for Biolife Sciences Inc.

How can I tell whether the Biolife Sciences Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biolife Sciences Inc. Over the past six months, the relative strength of its shares against the market has been -73.7%. At the current price of $0.45, shares in Biolife Sciences Inc are trading at -64.68% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Biolife Sciences Inc PE Ratio?

We were not able to find PE ratio data for Biolife Sciences Inc.

Who are the key directors of Biolife Sciences Inc?

Biolife Sciences Inc's management team is headed by:

Arthur Viola - SEC
Lloyd Glick - COO
John Rudy - CFO
Justin De Four - CHM
Nataliya Hearn - DRC
Brian Morales - DRC
Who are the major shareholders of Biolife Sciences Inc?

Here are the top five shareholders of Biolife Sciences Inc based on the size of their shareholding:

The MassMutual Trust Company, FSB Investment Advisor
Percentage owned: % (n/a shares)
Similar to BLFE
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.